Morphine Teva (Morphine Sulfate)

Morphine, the active ingredient in Morphine Teva, is an opioid analgesic presented as an oral formulation for oral use. It provides relief of moderate to severe pain in adult patients when other analgesics are insufficient. It is classified under Schedule II controlled substances and is indicated for management of acute postoperative pain, cancer‑related pain, and chronic severe pain.

GNH USA supplies Morphine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network adheres to stringent quality standards, ensuring product integrity across diverse regulatory environments.

Morphine Teva is an opioid analgesic used to manage pain conditions that involve the nociceptive pathway.

- Acute postoperative pain: provides rapid analgesia after surgical procedures - Cancer‑related pain: reduces severe pain associated with malignant disease - Chronic severe pain: offers long‑term relief for patients with persistent severe pain

Morphine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Vomiting - Sweating

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Addiction or physical dependence - Adrenal insufficiency - Anaphylaxis (severe allergic reaction) - Serotonin syndrome (rare)

When prescribing Morphine Teva, clinicians should observe several safety considerations.

- Assess pain severity: confirm that pain is moderate to severe before initiating therapy - Evaluate respiratory function: avoid use in patients with compromised ventilation - Monitor for signs of dependence: watch for misuse or addiction - Consider renal/hepatic impairment: dose adjustments may be required - Avoid concomitant CNS depressants: increased risk of sedation and respiratory depression - Store at ambient temperature: keep in original container, protect from moisture and light

Morphine Teva can interact with other medicines, requiring careful assessment.

Major Interactions (Avoid): - Other opioids: additive respiratory depression - Benzodiazepines: heightened sedation and respiratory risk - MAO inhibitors: risk of severe hypotension and serotonin syndrome - CYP3A4 inhibitors (e.g., ketoconazole): increased morphine levels - Alcohol: potentiates CNS depression

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): reduced efficacy - Anticholinergics: may worsen constipation - Diuretics: may enhance hypotensive effect - Antidepressants (SSRIs/SNRIs): possible serotonin syndrome - Antihistamines: increased drowsiness